Ara
Toplam kayıt 5, listelenen: 1-5
COVID-19: Hastalığı Artıran Risk Faktörleri ve Skorlama
(AVES Yayıncılık, 2021)
Şiddetli akut solunum sendromu virusu (SARS-CoV-2)’nun neden olduğu koronavirus hastalığı 2019 (COVID-19),
11 Mart 2020’de Dünya Sağlık Örgütü tarafından pandemi ilan edildikten sonra, kısa sürede büyük bir küresel ...
Pandemi Sürecinde Kronik Hepatit C
(AVES Yayıncılık, 2021)
Şiddetli akut solunum sendromu virusu (SARS-CoV-2)’nun neden olduğu koronavirus hastalığı 2019 (COVID-19), dünyayı etkilemiş, önemli morbidite ve mortalite nedeni olmuştur. COVID-19, esas olarak pulmoner belirtilerle ortaya ...
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
(BMC, 04.05.2021)
Background and objectives
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose ...
Neurological symptoms and findings in COVID-19: a prospective clinical study
(Taylor & Francis Group, 16.07.2021)
Objective: We sought to evaluate neurologic symptoms and findings in patients with COVID-
19 infection hospitalized in a ward and intensive care unit (ICU).
Methods: This study was designed as a prospective study. ...
Evaluation and follow-up of pain, fatigue, and quality of life in COVID-19 patients
(Korea Centers for Disease Control & Prevention, 2023)
Objectives: We evaluated pain, fatigue, anxiety, depression, and quality of life in patients hospitalized for coronavirus disease 2019 (COVID-19) and observed them over a period of 3 months. We also investigated the ...